Literature DB >> 23534734

Protective effects of Scutellaria barbata against rat liver tumorigenesis.

Zhi-Jun Dai1, Wen-Ying Wu, Hua-Feng Kang, Xiao-Bin Ma, Shu-Qun Zhang, Wei-Li Min, Wang-Feng Kang, Xiao-Bin Ma, Shu-Qun Zhang, Wei-Li Min, Wang-Feng Lu, Shuai Lin, Xi-Jing Wang.   

Abstract

Scutellaria barbata D. Don (S. barbata), a traditional Chinese medicine, is used to treat cancers, inflammation, and urinary diseases. This study aimed to determine any protective effects of S. barbata crude extract (CE-SB) against rat liver tumorigenesis induced by diethylnitrosamine (DENA). Liver malfunction indices in serum were measured by biochemical examination. Hematoxylin and eosin staining was performed to examine liver pathology. Contents of malondialdehyde (MDA) and superoxide dismutase (SOD) were measured in liver homogenates to evaluate oxidative stress. The levels of liver malfunction indices in the CE-SB groups, especially in the CE-SB high dose group, were lower than that of the model group (P<0.05). The results from histological examination indicated that the number of liver nodules in the CE-SB groups decreased compared with the model group (P<0.05). Content of MDA determined in liver was significantly decreased, and level of SOD elevated by CE-SB. CE-SB can inhibit experimental liver tumorigenesis and relieve hepatic injury in rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534734     DOI: 10.7314/apjcp.2013.14.1.261

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Inhibitory and ameliorative effect of heliomycin derived from actinomycete on induced hepatocellular carcinoma in rats.

Authors:  Ahmed S Alazzouni; Abdulla A Mahmoud; Mohamed M Omran; Ehab A Essawy; Mohga S Abdalla; Mohamed S Abdelfattah
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-08       Impact factor: 3.000

2.  Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice.

Authors:  Tao Gong; Chun-Fei Wang; Jia-Rui Yuan; Yu Li; Jun-Fei Gu; Bing-Jie Zhao; Li Zhang; Xiao-Bin Jia; Liang Feng; Shen-Lin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-03       Impact factor: 2.629

3.  Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice.

Authors:  Xuefeng Kan; Wanli Zhang; Ruxu You; Yanfeng Niu; Jianrong Guo; Jun Xue
Journal:  BMC Complement Altern Med       Date:  2017-01-13       Impact factor: 3.659

4.  Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota.

Authors:  Yunyan Zhang; Xuelian Li; Xinghua Li
Journal:  J Inflamm Res       Date:  2021-10-27

5.  AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis.

Authors:  Chaoyuan Huang; Hu Luo; Yuancheng Huang; Chongkai Fang; Lina Zhao; Peiwu Li; Chong Zhong; Fengbin Liu
Journal:  Int J Gen Med       Date:  2021-07-12

6.  Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies.

Authors:  Chin-Chuan Tsai; Chi-Shiuan Lin; Chun-Ru Hsu; Chiu-Ming Chang; I-Wei Chang; Li-Wei Lin; Chih-Hsin Hung; Jiun-Ling Wang
Journal:  BMC Complement Altern Med       Date:  2018-03-20       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.